# IDEXX LABORATORIES INC /DE (IDXX) FY2024 Annual Balance Sheet

- Company: IDEXX LABORATORIES INC /DE (IDXX)
- Period: As of 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-21, accession number 0000874716-25-000037
- Page: https://plicit.ai/financials/idxx/fy2024-annual-balance-sheet
- Chart image: https://plicit.ai/charts/idxx-fy2024-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 3,293,443,000 US dollars
- **Current assets**: 1,399,897,000 US dollars
- **Non-current assets**: 1,893,546,000 US dollars
- **Liabilities**: 1,698,130,000 US dollars
- **Current liabilities**: 1,067,916,000 US dollars
- **Non-current liabilities**: 630,214,000 US dollars
- **Equity**: 1,595,313,000 US dollars
- **Accounts receivable, net of allowance of $12,585 in 2024 and $9,501 in 2023**: 473,575,000 US dollars
- **Inventories**: 381,877,000 US dollars
- **Cash and cash equivalents**: 288,266,000 US dollars
- **Other current assets**: 256,179,000 US dollars
- **Property and equipment, net**: 713,123,000 US dollars
- **Other long-term assets**: 547,518,000 US dollars
- **Goodwill**: 405,100,000 US dollars
- **Operating lease right-of-use assets**: 116,129,000 US dollars
- **Intangible assets, net**: 111,676,000 US dollars
- **Accrued liabilities**: 502,119,000 US dollars
- **Credit facility**: 250,000,000 US dollars
- **Current portion of long-term debt**: 167,787,000 US dollars
- **Accounts payable**: 114,211,000 US dollars
- **Current portion of deferred revenue**: 33,799,000 US dollars
- **Long-term debt, net of current portion**: 449,786,000 US dollars
- **Long-term operating lease liabilities, net of current portion**: 97,836,000 US dollars
- **Other long-term liabilities**: 44,341,000 US dollars
- **Long-term deferred revenue, net of current portion**: 26,939,000 US dollars
- **Deferred income tax liabilities**: 11,312,000 US dollars
- **Retained earnings**: 5,332,438,000 US dollars
- **Additional paid-in capital**: 1,673,863,000 US dollars
- **Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,836 shares in 2024 and 107,506 shares in 2023; Outstanding: 81,604 shares in 2024 and 83,032 shares in 2023**: 10,784,000 US dollars
- **Deferred stock units: Outstanding: 60 units in 2024 and 59 units in 2023**: 5,885,000 US dollars
- **Treasury stock, at cost: 26,232 shares in 2024 and 24,474 shares in 2023**: negative 5,334,012,000 US dollars
- **Accumulated other comprehensive loss**: negative 93,645,000 US dollars
- **Gross equity (calculated)**: 7,022,970,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.